| Literature DB >> 36173104 |
Morgane Mitermite1, Dylan Gerard Ryan2,3, Mimmi L E Lundahl4,5, Sarah Case6, Niamh C Williams2, Ming Yang3, Roisin I Lynch4, Eimear Lagan7, Filipa M Lebre4, Aoife L Gorman4, Bojan Stojkovic1, Adrian P Bracken7, Christian Frezza3, Frederick J Sheedy6, Eoin M Scanlan5, Luke A J O'Neill2, Stephen V Gordon1, Ed C Lavelle4.
Abstract
Macrophages are a highly adaptive population of innate immune cells. Polarization with IFNγ and LPS into the 'classically activated' M1 macrophage enhances pro-inflammatory and microbicidal responses, important for eradicating bacteria such as Mycobacterium tuberculosis. By contrast, 'alternatively activated' M2 macrophages, polarized with IL-4, oppose bactericidal mechanisms and allow mycobacterial growth. These activation states are accompanied by distinct metabolic profiles, where M1 macrophages favor near exclusive use of glycolysis, whereas M2 macrophages up-regulate oxidative phosphorylation (OXPHOS). Here, we demonstrate that activation with IL-4 and IL-13 counterintuitively induces protective innate memory against mycobacterial challenge. In human and murine models, prior activation with IL-4/13 enhances pro-inflammatory cytokine secretion in response to a secondary stimulation with mycobacterial ligands. In our murine model, enhanced killing capacity is also demonstrated. Despite this switch in phenotype, IL-4/13 trained murine macrophages do not demonstrate M1-typical metabolism, instead retaining heightened use of OXPHOS. Moreover, inhibition of OXPHOS with oligomycin, 2-deoxy glucose or BPTES all impeded heightened pro-inflammatory cytokine responses from IL-4/13 trained macrophages. Lastly, this work identifies that IL-10 attenuates protective IL-4/13 training, impeding pro-inflammatory and bactericidal mechanisms. In summary, this work provides new and unexpected insight into alternative macrophage activation states in the context of mycobacterial infection.Entities:
Keywords: cytokine; immunology; immunometabolism; inflammation; innate immunity; macrophages; mouse; mycobacterium tuberculosis
Mesh:
Substances:
Year: 2022 PMID: 36173104 PMCID: PMC9555863 DOI: 10.7554/eLife.74690
Source DB: PubMed Journal: Elife ISSN: 2050-084X Impact factor: 8.713